<DOC>
	<DOC>NCT00226317</DOC>
	<brief_summary>A systematic open-label prospective pilot study to assess aripirazole for acute bipolar depression, with a secondary assessment of longer-term mood stabilization.</brief_summary>
	<brief_title>Aripiprazole in the Treatment of Bipolar Depression</brief_title>
	<detailed_description>Study is 6 weeks long with 7 clinical visits.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>DSMIV diagnosis of bipolar disorder, any subtype; MADRS &gt;16; MRS &lt; 10; not currently taking other mood stabilizers; women of reproductive potential must use an acceptable method of birth control Current substance abuse within past month; serious unstable medical condition; active suicidal ideation; pregnant, trying to become pregnant, or nursing; intent to continue or initiate herbal preparations</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>